PRESS RELEASE published on 06/16/2025 at 22:40, 7 months 14 days ago Sanofi: Disclosure of trading in own shares
PRESS RELEASE published on 06/16/2025 at 22:40, 7 months 14 days ago Sanofi : Déclaration des transactions sur actions propres
BRIEF published on 06/15/2025 at 17:27, 7 months 16 days ago Dupixent de Sanofi surpasse Xolair dans une étude de phase 4 pour la rhinosinusite chronique avec asthme Sanofi Dupixent CRSwNP Étude De Phase 4 Asthme
BRIEF published on 06/15/2025 at 17:27, 7 months 16 days ago Sanofi's Dupixent Surpasses Xolair in Phase 4 Study for Chronic Rhinosinusitis with Asthma Sanofi Dupixent Phase 4 Study CRSwNP Asthma
PRESS RELEASE published on 06/15/2025 at 17:22, 7 months 16 days ago Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study Dupixent outperformed Xolair in treating chronic rhinosinusitis with nasal polyps and coexisting asthma, showing superior efficacy across all key endpoints in a phase 4 study presented at EAACI Dupixent Phase 4 Study Asthma Xolair Chronic Rhinosinusitis
BRIEF published on 06/09/2025 at 23:14, 7 months 21 days ago Sanofi Releases May 2025 Voting Rights and Shares Data Voting Rights Shares Regulatory Compliance France Sanofi
BRIEF published on 06/09/2025 at 23:14, 7 months 21 days ago Sanofi publie les données relatives aux droits de vote et aux actions de mai 2025 Actions Droit De Vote Conformité Réglementaire France Sanofi
PRESS RELEASE published on 06/09/2025 at 23:09, 7 months 21 days ago Sanofi: Information concerning the total number of voting rights and shares - May 2025 Sanofi discloses total voting rights and shares information in compliance with French regulations. Details available on Sanofi's investor relations website Voting Rights Shares French Regulations Investor Relations Sanofi
PRESS RELEASE published on 06/09/2025 at 23:09, 7 months 21 days ago Sanofi: Informations relatives au nombre de droits de vote et d'actions - Mai 2025 Informations sur les droits de vote et actions de Sanofi conformément aux règlementations financières en vigueur. Détails disponibles sur le site Internet de Sanofi Autorité Des Marchés Financiers Droits De Vote Actions Règlement Financier Sanofi
BRIEF published on 06/09/2025 at 07:05, 7 months 22 days ago Sanofi prépare la distribution anticipée de Beyfortus pour contrer le VRS Production Sanofi AstraZeneca VRS Beyfortus
Published on 01/31/2026 at 03:15, 1 day 14 hours ago Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 01:40, 1 day 16 hours ago Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/30/2026 at 23:00, 1 day 18 hours ago Avidian Gold Corp. Announces Director Resignation
Published on 01/31/2026 at 15:54, 1 day 1 hour ago EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 1 day 5 hours ago JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 1 day 15 hours ago CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 1 day 19 hours ago Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 1 day 21 hours ago Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 18:40, 1 day 23 hours ago ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 17:45, 2 days ago Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 2 days ago Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 2 days 9 hours ago Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés